Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

mobile Cued Adherence Therapy (mCAT): a scalable habit formation intervention to improve blood pressure medication adherence based on a widely used smartphone app

Award Number: R01HL171706
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/22/2024
PERIOD OF PERFORMANCE END DATE: 05/31/2029

Group Awards By:

View Award Description

mobile Cued Adherence Therapy (mCAT): a scalable habit formation intervention to improve blood pressure medication adherence based on a widely used smartphone app - Project Summary/Abstract. Hypertension (high blood pressure) affects 1 in 3 of the over 90 million people currently enrolled in Medicaid, and is a leading cause of cardiovascular disease and stroke in the U.S. While multiple effective anti-hypertensive (AH) drugs are widely available in the U.S., they require high (≥80%) life- long medication adherence to successfully counter cardiovascular morbidity and mortality. Unfortunately, AH medication adherence is lowest among Medicaid enrollees compared to other insured populations, and nonadherence is a major barrier to controlled blood pressure. The mechanisms of present bias and habit strength have been shown to maintain behavior change in several settings, but have not been tested for maintaining high AH medication adherence. Incentives are effective for improving medication adherence in the short term, and may reduce present bias by helping people better internalize the future benefits of their actions, which in turn could maintain AH medication adherence. Therefore, we propose to partner with the widely-used, commercial Wellth smartphone app, where app users can earn incentives for sending photographic evidence of their daily pill taking. After withdrawing the Wellth-delivered incentives, we will measure adherence maintenance. Habitual pill-taking is another key strategy for maintaining behavior change, since habits performed in response to the same contextual cue for roughly four months are executed with high habit strength, i.e., are performed with little or no cognitive effort. Existing habit formation interventions have had difficulty effectively supporting participants, but behavioral economics suggests that providing small incentives for cueing the new behavior can effectively support habit formation. Thus, this study proposes to also adapt the Wellth app to reward cued AH pill taking. In a Stage III, 24-month 3-arm real-world efficacy trial, hypertensive adults with low (<80%) adherence from Arizona Complete Health’s Medicaid plan (n=600; 200 per group) will be randomly assigned to: 1) ‘Control’ group; 2) ‘Wellth Only’ that will receive daily incentives for submitting a picture of their AH pill taking; or 3) ‘Wellth+Cue’ that will be asked to describe the cue that will trigger their AH pill taking and send a second picture of the contextual cue, such as a coffee mug. A 4-month intervention will be followed by a 20-month post-intervention period to measure maintenance. The Primary Outcomes are mean AH medication adherence (days covered measured via Medicaid claims) and blood pressure (via at-home readings at baseline and months 4, 8, 12, and 24). Secondary Outcomes are healthcare utilization (emergency and inpatient visits) and the costs incurred by Medicaid (via claims data). After the study ends, interviews with stakeholders and participants (using a positive/negative deviance approach) will ask about potential implementation barriers to inform intervention refinements and cultural adaptation to prepare for Stage V implementation research in a future study. If found effective, the study has the potential for immediate scale-up for maintaining treatment adherence for hypertension and a range of other chronic conditions.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $718,310 )
2026	2026	ARIZONA STATE UNIVERSITY	1475 N SCOTTSDALE RD STE 200	SCOTTSDALE	AZ	85257	MARICOPA	USA	Cardiovascular Diseases Research	000	3	7/16/2026	NON-COMPETING CONTINUATION	$718,310
														Subtotal = $718,310

Issue Date FY: 2025 ( Subtotal = $738,713 )
2025	2025	ARIZONA STATE UNIVERSITY	660 S MILL AVENUE STE 204	TEMPE	AZ	85281	MARICOPA	USA	Cardiovascular Diseases Research	000	2	6/6/2025	NON-COMPETING CONTINUATION	$738,713
														Subtotal = $738,713

Issue Date FY: 2024 ( Subtotal = $758,655 )
2024	2024	ARIZONA STATE UNIVERSITY	660 S MILL AVENUE STE 204	TEMPE	AZ	85281	MARICOPA	USA	Cardiovascular Diseases Research	000	1	7/22/2024	NEW	$758,655
														Subtotal = $758,655

Grand Total All Awards = $2,215,678

Top

All Categories

About

Search

Reports

Data Submission

Award Information

mobile Cued Adherence Therapy (mCAT): a scalable habit formation intervention to improve blood pressure medication adherence based on a widely used smartphone app

Award Number: R01HL171706

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/22/2024

PERIOD OF PERFORMANCE END DATE: 05/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer